Subject: BICX Updates Investors on Progress in Clinics

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
BICX Updates Investors on Progress in Clinics
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)

End of Day:

Price: 0.041

Change (%): - 0.007 (14.58)

Volume: 22,000
BICX Chart

BioCorRx, Inc. Announces First Patients Treated in Wellness Center Pilot Using the Start Fresh Program

Los Angeles, July 6, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces update on the Company’s pilot program with Myriad Medical Marketing (MMM). The first location in the pilot program, Corona Physical Medicine (CPM), has just treated their first three patients using the Start Fresh Program. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879.

Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide. The original plan was to run the pilot in up to five centers, however, MMM has since decided that resources would be better utilized by focusing on one center. “We are thrilled to see the first patients being treated using our program at Corona Physical Medicine. It took a little longer than anticipated to get the pilot program running due to the intense level of training and coordination required to ensure that each patient has a great and safe experience. This pilot program is a completely different distribution model than we are accustomed to, however, the overall potential is exciting should it be deemed viable by all parties involved,” stated COO & interim CEO, Brady Granier.

Continue Reading

Top PerformerYesterday's Top Performer

Pazoo Inc. (Pink Sheets: PZOO)

End of Day:

Price: 0.007

Change (%): + 0.0004 (6.06)

Volume: 4,242,993
PZOO Chart

About Pazoo Inc.

Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee's and MA's license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill's top-rated testing protocols in select markets as we expand throughout the USA. Pazoo's subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website

Investor Info Sheet

Other Small Cap News

Company: CrowdGather, Inc. (OTCQB: CRWG)

CrowdGather, Inc. Announces 2015 Year End Results

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Specialty social media and gaming network CrowdGather, Inc. (OTCQB:CRWG) today announced financial results for the fiscal year ended April 30, 2015.

The Company also announced that it believes revenues will continue to increase in the current fiscal year and that those increases, combined with recent restructuring efforts finalizing the integration of its Plaor, Inc. subsidiary, have the Company striving to achieve positive operating cash flow in the current fiscal year.

Continue Reading

Company: Avita Medical Ltd. (OTCQX: AVMXY)

Avita Medical Data Demonstrating ReCell® Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology

Demonstrates 78% Repigmentation Compared to 0% in Control Groups

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jul 6, 2015) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study demonstrated that its single-use autologous cell suspension technology ReCell® was safe and effective in skin repigmentation for patients suffering with depigmented skin lesions caused by vitiligo and piebaldism. Results of the study have been published online and in the July 2015 print issue of the Journal of the American Academy of Dermatology, the official publication of the American Academy of Dermatology (AAD).

Continue Reading

Company: Banjo & Matilda, Inc. (OTCQB: BANJ)

Banjo & Matilda Secures $500,000 Investment

LOS ANGELES, CA--(Marketwired - July 06, 2015) - Banjo & Matilda, Inc. (OTCQB: BANJ) ("Banjo & Matilda" or the "Company"), an Australian e-commerce premium lifestyle brand, best known for its contemporary women's cashmere, announces the investment of $500,000 into the company, repayable over two years. The capital will be used for a number of growth initiatives designed to drive and support sales growth.

Forefront Capital Markets served as placement agent for the transaction and will provide corporate advisory services to the Company including assistance with additional capital raisings.

Continue Reading

Company: Balmoral Resources Ltd. (OTCQX: BALMF) (TSX-V: BAR)

Balmoral Rolls Out 3 Drills on Detour Trend Project, Quebec

2 Drills Currently Focused on Expansion and Confirmation of H3 Nickel Zone; Third Drill to Continue Expansion and Infill Drilling of Martiniere Gold System

VANCOUVER, BC--(Marketwired - July 06, 2015) - Balmoral Resources Ltd. ("Balmoral" or the "Company") (TSX: BAR) (OTCQX: BALMF) advised today that the summer/fall 2015 drill program on the Company's Detour Trend Project in Quebec is underway with several holes already completed. Three drills are now active on the Project and will remain so throughout the summer and fall. The focus of the summer/fall program will be to expand and delineate Balmoral's discoveries along the Grasset Nickel Trend and throughout the Martiniere Gold System. In total the Company anticipates completing approximately 20,000 metres of diamond drilling during the summer/fall program. The Grasset and Martiniere Properties form part of Balmoral's 700+ square kilometre Detour Trend Project located in west-central Quebec.

Continue Reading

Market News

By Alex Rosenberg: CNBC

Robert Shiller's shocking call: Buy Greek stocks!

While economist Robert Shiller finds American stocks to be expensive, he suggests that battered Greek equities may actually present a compelling opportunity for savvy investors.

The Nobel prize-winning Yale economist is famous for his valuation-based view of markets. In the long-run, low price-to-earnings ratios provide attractive long-term opportunities, and richly valued markets require caution, his work has shown.

Human psychology is what tends to get in the way and to create such opportunities, causing investors to become overly pessimistic at times when stocks are attractive, and far too optimistic in the midst of the bubbles, he has said.

Continue Reading

By Tanya Agrawal:

Wall St. falls as Greece concerns weigh

U.S. stocks fell in early trading on Monday after Greeks overwhelmingly rejected conditions of a rescue package from creditors, throwing the future of the country's euro zone membership into further doubt.

Stock markets globally fell, but analysts said the declines were less than expected due to expectations that the European Central Bank would act to limit any damage.

The ECB's governing council is due to hold a conference call on Monday afternoon to discuss the provision of emergency funding to Greece's banks. The call was originally to be held at noon. A new bailout deal is needed for Greece to meet a July 20 deadline to repay 3.9 billion dollars of bonds to the ECB.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks